Switzerland: Ethikkommission [clinicaltrials_resource:4296f65daf37ac94105c27f0f2d9feb0]
The Effects of Growth Hormone (GH) on Lipid Depots [clinicaltrials:NCT00491582]Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease [clinicaltrials:NCT00534651]Effects of Chocolate in Patients With Chronic Heart Failure [clinicaltrials:NCT00538941]Bronchoscopy and Bispectral Index (BIS) - Guided Sedation [clinicaltrials:NCT00839371]Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron [clinicaltrials:NCT00889499]clinicaltrials:NCT00944684clinicaltrials:NCT01039545clinicaltrials:NCT01126255clinicaltrials:NCT01189292clinicaltrials:NCT01522105clinicaltrials:NCT01574014Investigation of Lumbo-sacral Instability Using Custom Made Table - a Pilot Study [clinicaltrials:NCT01600417]Use of Human Fibrin Glue Versus Staples for Mesh Fixation in Laparoscopic Transabdominal Preperitoneal Hernioplasty [clinicaltrials:NCT01641718]Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [clinicaltrials:NCT01779882]This Trial is a Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma [clinicaltrials:NCT01808599]clinicaltrials:NCT02042287Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks [clinicaltrials:NCT02051218]Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents [clinicaltrials:NCT02053311]CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer [clinicaltrials:NCT02067741]clinicaltrials:NCT02068625Clinical Evaluation of an Integrated PET/MRI System [clinicaltrials:NCT02071706]Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina [clinicaltrials:NCT02088151]clinicaltrials:NCT02096120Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage [clinicaltrials:NCT02172703]clinicaltrials:NCT02179814Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence [clinicaltrials:NCT02196142]clinicaltrials:NCT02278796Integrated Approaches to Food Allergen and Allergy Risk Management [clinicaltrials:NCT02295397]Evaluating the Feasibility and Usability of Exergames in Stroke Patients With Visuo-spatial Neglect [clinicaltrials:NCT02353962]clinicaltrials:NCT02360046Rivaroxaban in Bariatric Surgery [clinicaltrials:NCT02438098]clinicaltrials:NCT02516059
oversight [clinicaltrials_vocabulary:oversight]
Switzerland: Ethikkommission [clinicaltrials_resource:4296f65daf37ac94105c27f0f2d9feb0]
Bio2RDF identifier
4296f65daf37ac94105c27f0f2d9feb0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4296f65daf37ac94105c27f0f2d9feb0
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:4296f65daf37ac94105c27f0f2d9feb0
title
Switzerland: Ethikkommission
@en
type
label
Switzerland: Ethikkommission [clinicaltrials_resource:4296f65daf37ac94105c27f0f2d9feb0]
@en